在胃肠道恶性瘤中准RAS.
Oluseyi Abidoye1, Celine Hoyek1, Tanios Bekaii-Saab1
1Department of Hematology and Oncology, Mayo Clinic, Arizona.
Clinical advances in hematology & oncology : H&O
|March 28, 2025
概括
准基尔斯大鼠肉瘤病毒 (KRAS) 突变,特别是KRAS G12C,对胃肠道癌症有希望. 新的小分子抑制剂对这些普遍的致癌驱动因素提供了希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠道瘤学 胃肠道瘤学
背景情况:
- 基尔斯鼠肉瘤病毒 (KRAS) 突变是胃肠道 (GI) 癌症的关键驱动因素,如胰腺和结直肠癌.
- 一个GTPase的KRAS蛋白调节关键的生存途径,使其成为一个重要的治疗点.
研究的目的:
- 审查肠道癌症中KRAS突变的分子基础.
- 探索针对KRAS突变的当前和新兴治疗策略.
- 讨论挑战,临床试验和KRAS向治疗的未来方向.
主要方法:
- 关于KRAS分子生物学的文献综述.
- 对胃肠道恶性瘤中KRAS突变的流行数据的分析.
- 检查当前和试验中的KRAS向治疗方法.
- 对临床试验结果和耐药性机制的审查.
主要成果:
- KRAS突变是肠胃癌中普遍存在的致癌驱动因素.
- 针对KRAS G12C突变的小分子抑制剂显示出治疗潜力.
- 目前正在进行的临床试验正在评估这些新型药物的疗效.
结论:
- 向KRAS突变,特别是G12C,代表了肠道癌症治疗的重大进展.
- 需要进一步的研究来克服耐药性并优化针对KRAS的治疗方法.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...


